{"transactions":[{"id":2577293,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":135700,"kind":"person","name":"Pano Arian","position":1,"cik":"0001867891","reported_name":"Pano Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Dev. Officer"}}],"security":"Restricted Share Units","published_at":"2021-09-07T21:19:21.000Z","date":"2021-09-02","kind":"grant","acquired":true,"shares":3888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."}],"balance_after":3888,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3888},"source":{"system":"sec-edgar","filing":"0001179110-21-008655","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021008655/edgar.xml","form_type":"4"}},{"id":2577292,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":135700,"kind":"person","name":"Pano Arian","position":1,"cik":"0001867891","reported_name":"Pano Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Dev. Officer"}}],"security":"Share Option","published_at":"2021-09-07T21:19:21.000Z","date":"2021-09-02","kind":"grant","acquired":true,"shares":23325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021."}],"balance_after":23325,"derivative":{"exercise_price":12.97,"expiration_date":"2031-09-01","underlying":"Class A Common Shares","underlying_shares":23325},"source":{"system":"sec-edgar","filing":"0001179110-21-008655","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021008655/edgar.xml","form_type":"4"}}]}